KCTD21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.433000E-01
Normal-vs-Stage2
4.974600E-01
Normal-vs-Stage3
9.253400E-01
Normal-vs-Stage4
2.549400E-01
Stage1-vs-Stage2
9.224200E-01
Stage1-vs-Stage3
3.619200E-01
Stage1-vs-Stage4
4.978200E-01
Stage2-vs-Stage3
3.627600E-01
Stage2-vs-Stage4
4.663600E-01
Stage3-vs-Stage4
2.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.948200E-01
Normal-vs-AfricanAmerican
6.806400E-02
Normal-vs-Asian
6.400000E-01
Caucasian-vs-AfricanAmerican
4.843500E-03
Caucasian-vs-Asian
9.932800E-01
AfricanAmerican-vs-Asian
4.136300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.022600E-01
Normal-vs-Female
4.384200E-01
Male-vs-Female
4.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.804800E-01
Normal-vs-Age(41-60Yrs)
1.569820E-01
Normal-vs-Age(61-80Yrs)
7.850200E-01
Normal-vs-Age(81-100Yrs)
7.695200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.687000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.939200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.405200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.17829999999264E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.088000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.333600E-01
Normal-vs-Daily Drinker
9.626400E-01
Normal-vs-Weekly Drinker
6.510800E-01
Normal-vs-Occasional Drinker
1.817430E-01
Normal-vs-Social Drinker
4.662400E-01
Non Drinker-vs-Daily Drinker
7.619200E-01
Non Drinker-vs-Weekly Drinker
5.404200E-01
Non Drinker-vs-Occasional Drinker
7.769800E-02
Non Drinker-vs-Social Drinker
2.890200E-01
Daily Drinker-vs-Weekly Drinker
4.550600E-01
Daily Drinker-vs-Occasional Drinker
6.263500E-02
Daily Drinker-vs-Social Drinker
2.520000E-01
Weekly Drinker-vs-Occasional Drinker
4.667800E-01
Weekly Drinker-vs-Social Drinker
7.599000E-01
Occasional Drinker-vs-Social Drinker
6.419800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.240400E-01
Normal-vs-Grade 2
2.539600E-02
Normal-vs-Grade 3
2.386400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.785600E-02
Grade 1-vs-Grade 3
2.355800E-01
Grade 1-vs-Grade 4
2.240400E-01
Grade 2-vs-Grade 3
5.046000E-01
Grade 2-vs-Grade 4
2.539600E-02
Grade 3-vs-Grade 4
2.386400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.169800E-01
Normal-vs-NonDiabetic
5.863800E-01
Diabetic-vs-NonDiabetic
5.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.266000E-01
Normal-vs-NoPancreatitis
6.522000E-01
Pancreatitis-vs-NoPancreatitis
4.568800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.130600E-01
Normal-vs-N1
5.049200E-01
N0-vs-N1
4.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.565600E-01
Normal-vs-TP53-NonMutant
6.356800E-01
TP53-Mutant-vs-TP53-NonMutant
2.755800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
